RNA Transcriptomics Market Demand, Segments and Forecast to 2028

Posted by Robert on September 6th, 2021

The global RNA transcriptomics market size is expected to reach USD 12.46 Billion in 2028 at a steady CAGR over the forecast period, according to latest analysis by Emergen Research.

Next, the market assessment report also takes into account the top performers and the new entrants when weighing up on the competitive landscape of the RNA Transcriptomics market for the forecast period, 2020 - 2028. Relevant and hard to find facts pertaining to the import and export status, supply chain management, product price, profit and gross margin are clearly explained through resources such as charts, tables and graphic images. A comprehensive coverage of various segments and the breakdown of their sale figures according to the regions form an important part of the scope of this study.  

Research Methodology

Data triangulation and market breakdown

Research assumptions Research data including primary and secondary data

Primary data includes breakdown of primaries and key industry insights

Secondary data includes key data from secondary sources

The study includes valuable data, including the breakdown of information of market by type, geography, product application and classification. An overview of the current and future trends examined in the report for the forecast period 2020 – 2027 aim at influencing the imperative advance prominent vendors are expected to have over their competitors.

Some Key Findings from the Report:

In October 2019, Ambry Genetics introduced a transcriptomic test +RNAinsight, which allows clinicians to simultaneously perform RNA and DNA testing and identify the risk of genetic mutations that may develop cancer.

Reagents segment is expected to register a revenue CAGR of 14.0% over the forecast period. This can be attributed to rising demand for high-quality reagents and growing research and development activities in the pharmaceutical sector.

Asia Pacific market revenue is expected to continue to register the fastest CAGR throughout the forecast period, which can be attributed to rising number of biotechnology and pharmaceutical companies and increasing focus on drug development.

Key players operating in the market are Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Merck KGaA, Agilent Technologies, Inc., Illumina, Inc., GenXPro GmbH, Fluidigm Corporation, CD Genomics, Sequentia Biotech SL, and Acobiom.

Report Objectives

Examine the size of the global RNA Transcriptomics market based on the parameters of value and volume.

Accurately calculate the market shares, consumption, and other essential aspects of different segments of the global RNA Transcriptomics market.

Explore the underlying dynamics of the global RNA Transcriptomics market.

Highlight significant trends of the global RNA Transcriptomics market based on factors including, production, revenue, and sales.

Extensively profile top players of the global RNA Transcriptomics market and showing how they compete in the industry.

Study manufacturing processes and the costs, product pricing, and various trends associated with them.

Analyze the performance of different regions and countries in the global RNA Transcriptomics market

Forecast the market size and share of all segments and regions in the global landscape.

Product Outlook (Revenue: USD Billion; 2018–2028)

Reagents

Instruments

Software

Service

Technology Outlook (Revenue: USD Billion; 2018–2028)

Microarrays

Polymerase Chain Reaction

RNA Sequencing

RNA Interference

Application Outlook (Revenue: USD Billion; 2018–2028)

Clinical Diagnostics

Toxicogenomics

Drug Discovery

Comparative Transcriptomics

End-use Outlook (Revenue: USD Billion; 2018–2028)

Hospitals

Academic & Research Institutes

Pharmaceutical & Biotechnology Companies

Contract Research Organizations

Regional scope: - North America; Europe; Asia Pacific; Central & South America; MEA

Here are the questions we answer...

What are the future opportunities in store for the vendors operating in the RNA Transcriptomics market?

What does the competitive landscape look like?

Which emerging technologies are believed to impact the RNA Transcriptomics market performance?

What are the key trends and dynamics?

Which regulations that will impact the industry?

Which segment will offer the most opportunity for growth between 2020 and 2028?

Where will most developments take place in the long term?

Who are the most prominent vendors and how much market share do they occupy?

What are the latest technologies or discoveries influencing the RNA Transcriptomics market growth worldwide?  

Read more@ https://www.emergenresearch.com/industry-report/rna-transcriptomics-market

Table of Content

Chapter 1. RNA Transcriptomics Market Methodology & Sources

    1.1. RNA Transcriptomics Market Definition

    1.2. RNA Transcriptomics Market Research Scope

    1.3. RNA Transcriptomics Market Methodology

    1.4. RNA Transcriptomics Market Research Sources

          1.4.1. Primary

          1.4.2. Secondary

          1.4.3. Paid Sources

    1.5. Market Estimation Technique

Chapter 2. Executive Summary

    2.1. Summary Snapshot, 2019-2028

Chapter 3. RNA Transcriptomics Market Key Insights

Chapter 4. RNA Transcriptomics Market Segmentation & Impact Analysis

Chapter 5. RNA Transcriptomics Market By Products Insights & Trends, Revenue (USD Million), Volume (Kilo Tons)

Chapter 6. RNA Transcriptomics Market By Types Insights & Trends, Revenue (USD Million), Volume (Kilo Tons)

Chapter 7. RNA Transcriptomics Market By Applications Insights & Trends Revenue (USD Million), Volume (Kilo Tons)

Chapter 8. RNA Transcriptomics Market By End Use Insights & Trends Revenue (USD Million), Volume (Kilo Tons)

Chapter 9. RNA Transcriptomics Market Regional Outlook

Chapter 10. Competitive Landscape

Continued…